Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PREDNISONE | 5MG | TABLET | Resolved | 2020-04-03 | 2020-05-21 | 110770 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2020-04-03 | 2020-05-21 | 110773 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2021-01-28 | 2021-03-04 | 132663 |
| TEVA-PREDNISONE | 5MG | TABLET | Resolved | 2022-12-01 | 2023-01-19 | 176761 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2022-12-01 | 2023-04-28 | 176764 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2023-06-26 | 2023-07-21 | 196448 |
| TEVA-PREDNISONE | 5MG | TABLET | Resolved | 2023-12-14 | 2024-02-15 | 213365 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2025-02-13 | 2025-02-28 | 250387 |
| TEVA-PREDNISONE | 50MG | TABLET | Resolved | 2025-06-19 | 2025-10-10 | 260645 |
| TEVA-PREGABALIN | 25MG | CAPSULE | Resolved | 2017-11-16 | 2018-02-21 | 29456 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2018-03-13 | 2018-05-11 | 42573 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2018-03-13 | 2018-05-30 | 42616 |
| TEVA-PREGABALIN | 75MG | CAPSULE | Resolved | 2020-03-26 | 2020-07-10 | 109638 |
| TEVA-PREGABALIN | 225MG | CAPSULE | Resolved | 2020-04-03 | 2020-05-08 | 110767 |
| TEVA-PREGABALIN | 150MG | CAPSULE | Resolved | 2020-04-10 | 2020-04-23 | 111854 |
| TEVA-PREGABALIN | 225MG | CAPSULE | Resolved | 2021-12-17 | 2021-12-23 | 151459 |
| TEVA-PREGABALIN | 25MG | CAPSULE | Resolved | 2022-01-20 | 2022-04-01 | 153183 |
| TEVA-PREGABALIN | 150MG | CAPSULE | Resolved | 2022-04-21 | 2022-08-16 | 159207 |
| TEVA-PREGABALIN | 50MG | CAPSULE | Resolved | 2022-06-03 | 2022-07-01 | 161967 |
| TEVA-PREGABALIN | 150MG | CAPSULE | Resolved | 2022-06-03 | 2022-10-01 | 161970 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 8MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258676 |
| ACT ENALAPRIL | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258682 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258697 |
| ACT FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258703 |
| TEVA-LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| TEVA-LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266377 |
| TEVA-LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266380 |
| TEVA-LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266383 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| TEVA-OLMESARTAN | 20MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117497 |